Innovative Predictive Analytics MYnd Analytics offers a unique decision support tool leveraging EEG data to enable personalized mental health treatments, providing a competitive edge for healthcare providers seeking advanced diagnostic solutions.

Expanding Telepsychiatry Services Through its wholly-owned subsidiary Arcadian Telepsychiatry, the company actively moves inpatient care to outpatient settings, presenting opportunities to partner with health systems aiming to improve access and reduce wait times for mental health services.

Strong Data Infrastructure With a comprehensive registry containing over 40,000 treatment outcomes across more than 11,000 patients, MYnd provides a valuable database for payers and providers interested in evidence-based, personalized therapy options.

Recent Funding & Growth Having raised $6 million and integrating with major platforms like Salesforce, MYnd is positioned for growth and technological expansion, making it a prime candidate for collaborations with organizations seeking innovative healthcare solutions.

Focus on Mental Health Innovation Operating within the growing mental health sector and competing with companies of similar size and scope, MYnd offers scalable, technology-driven solutions that can meet increasing demand for personalized psychiatric care.